Mitochondrial Myopathies Clinical Trial
Official title:
Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation Disorders: A Double-blind, Placebo-controlled, Cross Over Study
The purpose of this study is to investigate the potential beneficial effects of a daily supplement of Resveratrol (1000mg/day) on physical ability and on muscle metabolism in patients with verified mitochondrial myopathy and patients with a verified fatty acid oxidation defect of VLCAD and CPTII deficiencies. Investigators hypothesize an improved muscle metabolism, mitochondrial function, fatty acid oxidation and thus improvement of physical ability.
Study design: double-blind, randomized, placebo-controlled, cross-over study.
To ensure enough participants, and due to the risk of a heterogeneous cohort, a cross-over
design is chosen, where participants are their own controls. 10 patients with mitochondrial
myopathy and 10 patients with fatty acid oxidation defects will be included. Eligible
patients will be randomized using a 1:1 assignment ratio to receive placebo or RSV first.
Each treatment will be administered orally twice daily for 8 weeks, followed by a 4 weeks
wash-out, and afterwards a new 8-week treatment period.
During the 20-week trial period, subjects will visit the trial site on five occasions, for
functional assessments (cycle ergometer testing), blood sampling and questionnaires.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06051448 -
Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Primary Mitochondrial Disease (PMD).
|
Phase 1/Phase 2 | |
Completed |
NCT02909400 -
The KHENERGY Study
|
Phase 2 | |
Completed |
NCT04165239 -
The KHENERGYZE Study
|
Phase 2 | |
Recruiting |
NCT06080568 -
Human Mitochondrial Stress-driven Obesity Resistance
|
||
Recruiting |
NCT06080581 -
Mitochondrial Dysfunctions Driving Insulin Resistance
|
||
Completed |
NCT02255422 -
RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR
|
Phase 2 | |
Completed |
NCT05012358 -
Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine
|
||
Recruiting |
NCT05569122 -
Applying pGz in Mitochondrial Disease
|
Phase 1 | |
Completed |
NCT03888716 -
A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Disease
|
Phase 1 | |
Completed |
NCT05063721 -
MABs Therapy m.3243A>G Mutation Carriers
|
Phase 1 | |
Completed |
NCT03973203 -
Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients
|
N/A | |
Recruiting |
NCT05200702 -
Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders
|
N/A | |
Recruiting |
NCT04086329 -
Validation of Oxygen Nanosensor in Mitochondrial Myopathy
|
Phase 1 | |
Completed |
NCT03513835 -
Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies
|
||
Completed |
NCT04538521 -
NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients
|
N/A | |
Recruiting |
NCT05554835 -
Global Registry and Natural History Study for Mitochondrial Disorders
|
||
Completed |
NCT03432871 -
Nicotinamide Riboside and Mitochondrial Biogenesis
|
N/A | |
Completed |
NCT02375438 -
Nutritional Assessment in Mitochondrial Cytopathy
|
N/A | |
Recruiting |
NCT05346627 -
Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tolerance.
|
N/A | |
Recruiting |
NCT05199740 -
mtDNA Mutation Load Analysis in Mesoangioblasts
|